Many Hispanics with diabetes unaware of potential eye disease, do not receive eye exams

July 14, 2008

Hispanic patients with diabetes appear to have less frequent eye examinations than the national average for Hispanic individuals, and many are not aware of the potential ocular complications of diabetes, according to a report in the July issue of Archives of Ophthalmology, one of the JAMA/Archives journals.

One in five Hispanic individuals older than 40 years currently has diabetes, and almost half have diabetic retinopathy, a related eye disease, according to background information in the article. "The limited use of health care services in minority groups may make them more susceptible to the complications of uncontrolled diabetes," the authors write. "In addition, a substantial proportion of those with diabetes are unaware of their condition, although already presenting signs of moderate to severe diabetic retinopathy. The importance of appropriate and timely care for diabetic retinopathy or macular edema [swelling in the retina] is paramount, as it is the leading cause of visual loss among working-age Hispanic individuals."

Beatriz Muñoz, M.Sc., of the Wilmer Eye Institute, Johns Hopkins University, Baltimore, and colleagues interviewed 349 randomly selected Hispanic individuals without diabetes and a group of 204 Hispanic individuals with diabetes. Participants answered questions about demographic information, health care habits and knowledge of diabetes and diabetic retinopathy.

The researchers found that: "The lack of correct information about diabetes and diabetic eye disease in this population of Hispanic individuals should be of great concern," the authors conclude. "The frequency of dilated eye examinations among people with diabetes was unacceptable, and places this population at risk of visual loss. These deficiencies need to be rectified with a culturally appropriate health education campaign, and with innovative ways to reduce barriers to health care."
(Arch Ophthalmol. 2008;126[7]:968-974. Available pre-embargo to the media at

Editor's Note: This project was supported by a grant from the National Eye Institute. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

The JAMA Network Journals

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to